Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 18.62----

What is the latest Price to Cash Earnings (PCE) ratio of EMCURE PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of EMCURE PHARMACEUTICALS is 18.62 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202518.62
Mar2024-
Mar2023-
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of EMCURE PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 18.62
0
Mar2024 0
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹29,051.5 Cr 1.2% 4.2% 63% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,782.0 Cr -2.5% 4.7% 7.1% Stock Analytics
DIVIS LABORATORIES ₹163,125.0 Cr -2.1% -0.2% 7.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,252.0 Cr -3.4% 0.7% 39.1% Stock Analytics
DR REDDYS LABORATORIES ₹108,025.0 Cr -1.9% 2% 16.1% Stock Analytics
CIPLA ₹102,443.0 Cr -4.3% -6.5% -11.9% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

1.2%

4.2%

63%

SENSEX

-0.2%

-7.2%

3.5%


You may also like the below Video Courses